Biomarkers uPA/PAI-1 in breast cancer: Benefit, harm of test unclear
Monday, October 20, 2014 - 14:31
in Health & Medicine
Since studies are lacking, it remains unclear whether certain patients have a benefit if the decision for or against adjuvant chemotherapy is based on the concentration of uPA and PAI-1, a new report states.